• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶与含凝血酶的生物材料在疾病治疗中的应用

Thrombin and Thrombin-Incorporated Biomaterials for Disease Treatments.

机构信息

State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, Jiangsu, 211189, P. R. China.

出版信息

Adv Healthc Mater. 2024 Feb;13(5):e2302209. doi: 10.1002/adhm.202302209. Epub 2023 Nov 16.

DOI:10.1002/adhm.202302209
PMID:37897228
Abstract

Thrombin, a coagulation-inducing protease, has long been used in the hemostatic field. During the past decades, many other therapeutic uses of thrombin have been developed. For instance, burn treatment, pseudoaneurysm therapy, wound management, and tumor vascular infarction (or tumor vasculature blockade therapy) can all utilize the unique and powerful function of thrombin. Based on their therapeutic effects, many thrombin-associated products have been certificated by the Food and Drug Administration, including bovine thrombin, human thrombin, recombinant thrombin, fibrin glue, etc. Besides, several thrombin-based drugs are currently undergoing clinical trials. In this article, the therapeutic uses of thrombin (from the initial hemostasis to the latest cancer therapy), the commercially available drugs associated with thrombin, and the pros and cons of thrombin-based therapeutics (e.g., adverse immune responses related to bovine thrombin, thromboinflammation, and vasculogenic "rebounds") are summarized. Further, the current challenges and possible future research directions of thrombin-incorporated biomaterials and therapies are discussed. It is hoped that this review may provide a valuable reference for researchers in this field and help them to design safer and more effective thrombin-based drugs for fighting against various intractable diseases.

摘要

凝血酶是一种促凝血的蛋白酶,长期以来一直用于止血领域。在过去的几十年中,人们已经开发出了许多其他的凝血酶治疗用途。例如,烧伤治疗、假性动脉瘤治疗、伤口管理和肿瘤血管梗死(或肿瘤血管阻断治疗)都可以利用凝血酶的独特而强大的功能。基于其治疗效果,许多与凝血酶相关的产品已获得美国食品和药物管理局的认证,包括牛凝血酶、人凝血酶、重组凝血酶、纤维蛋白胶等。此外,目前还有几种基于凝血酶的药物正在进行临床试验。本文总结了凝血酶的治疗用途(从最初的止血到最新的癌症治疗)、与凝血酶相关的市售药物,以及基于凝血酶的治疗方法的优缺点(例如,与牛凝血酶相关的不良免疫反应、血栓炎症和血管生成“反弹”)。此外,还讨论了当前凝血酶结合生物材料和治疗方法所面临的挑战和未来可能的研究方向。希望这篇综述能为该领域的研究人员提供有价值的参考,并帮助他们设计出更安全、更有效的基于凝血酶的药物,以对抗各种难治性疾病。

相似文献

1
Thrombin and Thrombin-Incorporated Biomaterials for Disease Treatments.凝血酶与含凝血酶的生物材料在疾病治疗中的应用
Adv Healthc Mater. 2024 Feb;13(5):e2302209. doi: 10.1002/adhm.202302209. Epub 2023 Nov 16.
2
A review of three stand-alone topical thrombins for surgical hemostasis.三种用于手术止血的独立外用凝血酶的综述。
Clin Ther. 2009 Jan;31(1):32-41. doi: 10.1016/j.clinthera.2009.01.005.
3
A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.重组凝血酶与牛凝血酶作为外周动脉搭桥和动静脉移植手术患者止血辅助剂的比较。
J Vasc Surg. 2008 Jun;47(6):1266-73. doi: 10.1016/j.jvs.2008.01.034. Epub 2008 Apr 28.
4
A review of the therapeutic uses of thrombin.凝血酶的治疗用途综述。
Thromb Haemost. 2004 May;91(5):851-60. doi: 10.1160/TH03-12-0792.
5
Acquired factor V deficiency associated with exposure to bovine thrombin in a burn patient.
J Burn Care Res. 2010 Mar-Apr;31(2):353-60. doi: 10.1097/BCR.0b013e3181d0f5b4.
6
Bovine thrombin: history, use, and risk in the surgical patient.牛凝血酶:外科手术患者的历史、用途及风险
Vascular. 2008 Mar-Apr;16 Suppl 1:S29-36.
7
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.获得性FV抑制剂:牛凝血酶暴露导致的不必要医源性并发症。
Transfusion. 2002 Jan;42(1):18-26. doi: 10.1046/j.1537-2995.2002.00011.x.
8
Alginate based biomaterials for hemostatic applications: Innovations and developments.用于止血应用的藻酸盐基生物材料:创新与发展。
Int J Biol Macromol. 2024 Apr;264(Pt 2):130771. doi: 10.1016/j.ijbiomac.2024.130771. Epub 2024 Mar 10.
9
The clinical use and immunologic impact of thrombin in surgery.凝血酶在手术中的临床应用及免疫影响。
Semin Thromb Hemost. 2006 Apr;32 Suppl 1:98-110. doi: 10.1055/s-2006-939559.
10
Targeting hemostasis-related moieties for tumor treatment.针对止血相关分子进行肿瘤治疗。
Thromb Res. 2020 Mar;187:186-196. doi: 10.1016/j.thromres.2020.01.019. Epub 2020 Jan 15.

引用本文的文献

1
Research progress of liposomal bupivacaine and its value in perioperative pain management.脂质体布比卡因的研究进展及其在围手术期疼痛管理中的价值。
JPRAS Open. 2025 Jul 5;45:311-316. doi: 10.1016/j.jpra.2025.06.022. eCollection 2025 Sep.
2
Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy.免疫格局中的血小板信号传导:综合机制与临床治疗
Biomark Res. 2024 Dec 31;12(1):164. doi: 10.1186/s40364-024-00700-y.
3
Tannic acid coating gauze immobilized with thrombin with ultra-high coagulation activity and antimicrobial property for uncontrollable hemorrhage.
单宁酸涂层纱布固定凝血酶具有超高凝血活性和抗菌性能,可用于控制不可控制的出血。
Sci Rep. 2024 Jul 12;14(1):16139. doi: 10.1038/s41598-024-67049-y.
4
Sono-responsive smart nanoliposomes for precise and rapid hemostasis application.用于精确快速止血应用的声响应智能纳米脂质体
RSC Adv. 2024 May 13;14(22):15491-15498. doi: 10.1039/d3ra08445k. eCollection 2024 May 10.